Appili Therapeutics Stock Price Patterns
| APLIF Stock | USD 0.01 0.00 0.00% |
Momentum 34
Sell Stretched
Oversold | Overbought |
Using Appili Therapeutics hype-based prediction, you can estimate the value of Appili Therapeutics from the perspective of Appili Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Appili Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Appili because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Appili Therapeutics after-hype prediction price | USD 0.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Appili |
Appili Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Appili Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Appili Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Appili Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Appili Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Appili Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Appili Therapeutics' historical news coverage. Appili Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 7.14, respectively. We have considered Appili Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Appili Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Appili Therapeutics is based on 3 months time horizon.
Appili Therapeutics Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Appili Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Appili Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Appili Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 7.13 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.01 | 0.01 | 28.57 |
|
Appili Therapeutics Hype Timeline
Appili Therapeutics is presently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Appili is forecasted to decline in value after the next headline, with the price expected to drop to 0.01. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -28.57%, whereas the daily expected return is presently at -0.16%. The volatility of related hype on Appili Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.01. About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.48. Some equities with similar Price to Book (P/B) outperform the market in the long run. Appili Therapeutics recorded a loss per share of 0.32. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out Appili Therapeutics Basic Forecasting Models to cross-verify your projections.Appili Therapeutics Related Hype Analysis
Having access to credible news sources related to Appili Therapeutics' direct competition is more important than ever and may enhance your ability to predict Appili Therapeutics' future price movements. Getting to know how Appili Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Appili Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AGNPF | Algernon Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.10) | 14.41 | (14.50) | 42.24 | |
| RNUGF | ReNeuron Group Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ADXS | Ayala Pharmaceuticals | 0.00 | 0 per month | 21.95 | 0.22 | 122.19 | (53.64) | 734.55 | |
| IBOGF | Universal Ibogaine | 0.00 | 0 per month | 18.69 | 0.12 | 52.50 | (31.03) | 141.59 | |
| NMLSF | Nova Mentis Life | 0.00 | 0 per month | 5.08 | 0.12 | 16.00 | (10.15) | 42.84 | |
| RGBP | Regen BioPharma | 0.00 | 0 per month | 0.00 | (0.14) | 20.00 | (28.57) | 78.35 | |
| VGLS | Vg Life Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AAGH | America Great Health | 0.00 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IBXXF | Imagion Biosystems Limited | 0.00 | 0 per month | 0.00 | 0.1 | 0.00 | 0.00 | 0.00 | |
| HESG | Health Sciences Gr | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appili Therapeutics Additional Predictive Modules
Most predictive techniques to examine Appili price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Appili using various technical indicators. When you analyze Appili charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Appili Therapeutics Predictive Indicators
The successful prediction of Appili Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Appili Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Appili Therapeutics based on analysis of Appili Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Appili Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Appili Therapeutics's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for Appili Pink Sheet analysis
When running Appili Therapeutics' price analysis, check to measure Appili Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Appili Therapeutics is operating at the current time. Most of Appili Therapeutics' value examination focuses on studying past and present price action to predict the probability of Appili Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Appili Therapeutics' price. Additionally, you may evaluate how the addition of Appili Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |